Evidence map›Paper›PMID 35614315›Full record

ArticleCommunications biology2022

Nsun4 and Mettl3 mediated translational reprogramming of Sox9 promotes BMSC chondrogenic differentiation.

Lin Yang, Zhenxing Ren, Shenyu Yan, Ling Zhao, Jie Liu, Lijun Zhao, Zhen Li, Shanyu Ye, Aijun Liu, Xichan Li and 5 more

Open access · goldAbstract read
In one paragraph

Article in Communications biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
5.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 62 citations in OpenAlex.

  1. Article
  2. mMolecular medicine reports · 2026
    Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Advances in RNA modification in myocardial fibrosis (Review).International journal of molecular medicine · 2025
    Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 9 institutions in 2 countries.

Lin Yang *Shenzhen Hospital of Integrated Traditional Chinese and Western Medicine, Shenzhen, 518101, Guangdong, China.ORCID 0000-0002-2240-3017
Zhenxing Ren *Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, 200233, China.
Shenyu Yan *Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, 61001-89999, China.
Ling ZhaoAcademy of Integrative Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.
Jie LiuShenzhen Hospital of Integrated Traditional Chinese and Western Medicine, Shenzhen, 518101, Guangdong, China.
Lijun ZhaoShenzhen Hospital of Integrated Traditional Chinese and Western Medicine, Shenzhen, 518101, Guangdong, China.
Zhen LiShenzhen Hospital of Integrated Traditional Chinese and Western Medicine, Shenzhen, 518101, Guangdong, China.
Shanyu YeDepartment of Anatomy, School of Basic Medical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, 510006, China.
Aijun LiuDepartment of Anatomy, School of Basic Medical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, 510006, China.
Xichan LiSchool of Chinese Herbal Medicine, Guangzhou University of Chinese Medicine, Guangzhou, 510006, China.
Jiasong GuoDepartment of Histology and Embryology, Southern Medical University, Guangzhou, 510515, China.ORCID 0000-0002-7885-2903
Wei ZhaoRNA Biomedical Institute, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China.ORCID 0000-0002-0774-2571
Weihong KuangGuangdong Key Laboratory for Research and Development of Natural Drugs, Key Laboratory of Research and Development of New Medical Materials of Guangdong Medical University, School of Pharmacy, Guangdong Medical University, Dongguan, China.
Helu LiuShenzhen Hospital of Integrated Traditional Chinese and Western Medicine, Shenzhen, 518101, Guangdong, China. liuhelu@21cn.com.
Dongfeng ChenDepartment of Anatomy, School of Basic Medical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, 510006, China. chen888@gzucm.edu.cn.ORCID 0000-0003-1263-2374
Guangzhou University of Chinese Medicine · CNShenzhen Pingle Orthopedic Hospital · CNShanghai University of Traditional Chinese Medicine · CNChinese University of Hong Kong · HKGuangdong Medical College · CNIntegrated Chinese Medicine (China) · CNShanghai Jiao Tong University · CNSouthern Medical University · CNSun Yat-sen University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The chondrogenic differentiation of bone marrow-derived mesenchymal stem cells (BMSCs) has been used in the treatment and repair of cartilage defects; however, the in-depth regulatory mechanisms by which RNA modifications are involved in this process are still poorly understood. Here, we found that Sox9, a critical transcription factor that mediates chondrogenic differentiation, exhibited enhanced translation by ribosome sequencing in chondrogenic pellets, which was accompanied by increased 5-methylcytosine (m

Indexed as

ChondrogenesisMesenchymal Stem CellsAdenosineCell DifferentiationRNA, MessengerAdenosineRNA, Messenger

Identifiers

PMID35614315
PMCPMC9133052
OpenAlexW4281490750

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.